Bausch Health Companies Inc. insider trading
In twelve months insiders at Bausch Health Companies bought $15.6M and sold $507K on the open market; 5 of the 5 sales were under plans set months before.
New to this? How to read this page
- Insiders are the people who run the company: officers, directors and owners of 10% or more. They must report a trade on Form 4 within two business days.
- A purchase on the open market is the strongest sign: the insider spent their own money.
- A sale under a trading plan (Rule 10b5-1) says little: its dates were fixed months before. Sales outside a plan say more, but insiders sell for many reasons, such as taxes or a house.
- Grants, option exercises and shares held back for tax are left out.
- What is a Form 4? · Form 4 codes
What kind of trades
1 purchase worth $15.6M against 5 sales worth $507K; 5 of the sales were under plans set months before.
Every Form 4 line of the last twelve months, counted by kind. The grades come from the filing itself: whether the insider paid cash, whether a plan set the date, whether pay was taken in stock by choice.
Insider trades on the share price
last twelve months18 marks over twelve months, each in its grade: solid for the stronger signs, hollow or grey for the ones that say little.
The blue line is the daily close over twelve months. Each mark is one insider's trades on one day, on that day's price, sized by dollar value. Solid marks are the stronger signs; hollow and grey marks say little. Hover or tap a mark for who, how much and why.
Trades worth a closer look
A purchase stands out when two or more of these hold: a senior insider, several insiders buying within 90 days, a fall of 10% or more in the three months before, or over $1 million. A sale outside a plan is judged the same way. These are the Feed's rules.
Who traded
dollars, twelve months7 insiders traded. The most: Paulson & Co. Inc., purchase $15.6M.
One row per insider, sold to the left and bought to the right, split by grade: the paler part of a bar is the part that says little.
How it compares
every company on the siteOpen-market sales, twelve months
Open-market purchases, twelve months
The bar ranks every company on the site from the lowest on the left to the highest on the right, in three equal thirds; the small figures under it are the values where each third starts, and the black tick is the middle company. The orange dot is this company; the grey ticks are the other companies in its industry (hover or tap for names). A hatched block is companies tied at none.
Every Form 4 line
| Traded | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 30 September 2026 | Paulson John | Director | Took pay in stockone of 3 insiders the same day · Common Shares, No Par Value | 10,720 | $5.83 | $62,498 | Form 4 |
| 30 September 2026 | Leung Sandra | Director | Took pay in stockone of 3 insiders the same day · Common Shares, No Par Value | 5,789 | $5.83 | $33,750 | Form 4 |
| 30 September 2026 | Wechsler Amy B | Director | Took pay in stockone of 3 insiders the same day · Common Shares, No Par Value | 1,179 | $5.83 | $6,874 | Form 4 |
| 19 August 2026 | Lenar Aimee J. | President, US Pharma | Saletrading plan set in advance · Form 144 notice 19 August 2026 | 36,827 | $7.03 | $258,894 | Form 4 |
| 30 June 2026 | Wechsler Amy B | Director | Took pay in stockone of 3 insiders the same day · Common Shares, No Par Value | 1,394 | $4.93 | $6,872 | Form 4 |
| 30 June 2026 | Paulson John | Director | Took pay in stockone of 3 insiders the same day · Common Shares, No Par Value | 12,677 | $4.93 | $62,498 | Form 4 |
| 30 June 2026 | Leung Sandra | Director | Took pay in stockone of 3 insiders the same day · Common Shares, No Par Value | 6,845 | $4.93 | $33,746 | Form 4 |
| 19 May 2026 | Lee Frank D. | Director | Saletrading plan set in advance · Form 144 notice 19 May 2026 | 24,456 | $5.43 | $132,796 | Form 4 |
| 31 March 2026 | Leung Sandra | Director | Took pay in stockone of 3 insiders the same day · Common Shares, No Par Value | 5,946 | $5.40 | $32,108 | Form 4 |
| 31 March 2026 | Paulson John | Director | Took pay in stockone of 3 insiders the same day · Common Shares, No Par Value | 11,574 | $5.40 | $62,500 | Form 4 |
| 31 March 2026 | Wechsler Amy B | Director | Took pay in stockone of 3 insiders the same day · Common Shares, No Par Value | 1,273 | $5.40 | $6,874 | Form 4 |
| 3 March 2026 | Carson Seana | EVP, General Counsel | Saletrading plan set in advance · Form 144 notice 3 March 2026 | 4,420 | $5.77 | $25,503 | Form 4 |
| 2 March 2026 | Carson Seana | EVP, General Counsel | Saletrading plan set in advance · Form 144 notice 3 March 2026 | 6,856 | $5.78 | $39,628 | Form 4 |
| 27 February 2026 | Carson Seana | EVP, General Counsel | Saletrading plan set in advance · Form 144 notice 27 February 2026 | 8,388 | $5.95 | $49,909 | Form 4 |
| 31 December 2025 | Paulson John | Director | Took pay in stockone of 3 insiders the same day · Common Shares, No Par Value | 8,992 | n/a | n/a | Form 4 |
| 31 December 2025 | Leung Sandra | Director | Took pay in stockone of 3 insiders the same day · Common Shares, No Par Value | 4,586 | n/a | n/a | Form 4 |
| 31 December 2025 | Wechsler Amy B | Director | Took pay in stockone of 3 insiders the same day · Common Shares, No Par Value | 989 | n/a | n/a | Form 4 |
| 25 November 2025 | Paulson & Co. Inc., by Managed Funds | 10% owner | Purchaseafter a 12% fall over three months · 25% below its one-year high | 2,500,000 | $6.25 | $15.6 million | Form 4 |